Newsroom | Qiming Venture Partners

11/2022

Portfolio News
Insilico Medicine Signs Strategic Research Collaboration with Sanofi worth up to $1.2 Billion
Qiming News
Qiming Monthly Newsletter (October 2022)

10/2022

Portfolio News
The Case Report of Belief BioMed’s Hemophilia B Gene Therapy Drug Candidate BBM-H901 Published in The New England Journal of Medicine
Portfolio News
CANbridge Announced Encouraging Development in Maralixibat in Rare Liver Disease
Portfolio News
CanSinoBIO Celebrates the Rollout of Inhaled Vaccine Convidecia Air™ in Shanghai
Portfolio News
OriCell's GPRC5D CAR-T Received Orphan Drug Designation from FDA
Portfolio News
WeRide and Hyundai Plan to Fuel Self-driving with Hydrogen in China
Portfolio News
Abbisko Obtained Phase III Clinical Trial Approval for ABSK021 from CDE of NMPA
Qiming News
Qiming Insights | Qiming’s Kan Chen on Scientist Entrepreneurship in Healthcare
Portfolio News
TigerGraph Announced Commitment to Support openCypher in GSQL
Portfolio News
Qiming Venture Partners' portfolio Transwarp successfully lists on STAR Market
Portfolio News
AmoyDx and BeiGene Announced Strategic Cooperation on HER2 Companion Diagnostics
Portfolio News
CANbridge in Oral Presentation at ESGCT 29th Annual Congress
Portfolio News
Jacobio Pharma Announced a Clinical Trial Collaboration Agreement with Merck
Qiming News
Qiming’s Duane Kuang Awarded Fortune China’s 2022 TOP 30 Most Influential Investors in China
Qiming News
Qiming's Grace Lee Awarded TOP 10 China VC/PE CFO in 2022
Qiming News
Qiming Monthly Newsletter (September 2022)
Portfolio News
Antengene Announced Upcoming Presentations at SITC 2022
Portfolio News
Schrödinger Forged a Drug Design Collaboration with Eli Lilly
Portfolio News
Ark Biopharmaceutical Presented Positive Results at 12th International RSV Symposium
Portfolio News
CanSinoBIO to Present Latest Data at the World Vaccine Congress Europe 2022
Portfolio News
dMed-Clinipace Announced Corporate Name Change to Caidya

09/2022

Portfolio News
Zai Lab and Seagen Announced Regional Strategic Collaboration and License Agreement
Qiming News
Nisa Leung on Reuters: 'Overinvested' China Healthcare Sector Set for Shake Up
Qiming News
Oscar Zhang Shared with BioWorld on Recent Funding of Koutech
Qiming News
Qiming's Nisa Leung Awarded 2021 Leader of the Year
Portfolio News
OriCell Therapeutics Receives Implied License from NMPA for Ori-C101 IND Application
Portfolio News
Surgical Robot Platform Company Koutech Nets Hundreds of Mns of RMB in Series A Round
Portfolio News
Insilico Medicine Clinches an Award at the HKB Technology Excellence Awards
Portfolio News
Antengene Announces ATG-101 Granted Orphan Drug Designation by the U.S. FDA
Portfolio News
Naked Eye 3D Microscope First Presented at ESE by Bondent Group
Portfolio News
Roborock Ranks First among Robot Vacuum Makers Globally in Terms of Sales Volume
Portfolio News
CanSinoBIO's Xuefeng Yu Talked Exclusively with Bloomberg on the New Convidecia Air™
Portfolio News
Insta360 Announced 360 Action Cam X3 That Makes Magic Out of the Action
Portfolio News
Genor Biopharma's GB261 Phase I/II Clinical Trial is Officially Launched in China
Portfolio News
Jacobio Receives CDE Approval for JAB-21822's Phase II Pivotal Study in China
Portfolio News
SinocellTech Receives First NMPA Approval for A Homegrown Anti-CD20 Mab
Portfolio News
Structure Therapeutics’ Raymond Stevens and Zai Lab’s Samantha Du Included in 2022 PharmaVoice 100 List
Qiming News
Qiming Monthly Newsletter (August 2022)
Portfolio News
CanSinoBIO's Convidecia Air™ Receives Approval in China
Portfolio News
Antengene Announces XPOVIO® Included for Reimbursement by the PBS in Australia
Portfolio News
Gan & Lee's GZR4 Completed the First Subject Administration in Phase I Clinical Trial
Qiming News
Qiming Venture Partners' Nisa Leung Discusses Biotech Opportunities on Bloomberg

08/2022

Portfolio News
Atom Semiconductor and DP Technology were Included in Forbes Asia 100 To Watch 2022
Portfolio News
Prismlab Completes Series C Financing of 200m RMB Led by Qiming Venture Partners
Portfolio News
Belief BioMed's BBM-H901 Injection Receives China CDE's Breakthrough Therapy Designation
Portfolio News
DeepWay Completes Series A Round of 460m RMB Led by Qiming Venture Partners
Portfolio News
Several Key Research Supported by Amoy Diagnostics were Presented at WCLC 2022
Portfolio News
ZhenGe Biotech Announced the Completion of 100m RMB Series C+ Funding
Portfolio News
CanSinoBIO's Convidecia Air™ Receives Clinical Trial Approval in Malaysia
Portfolio News
Belief BioMed's BBM-H901 Injection was Granted Orphan Drug Designation by FDA
Qiming News
Qiming Monthly Newsletter (July 2022)
Qiming News
Qiming Insights | Exclusive interview with Duane Kuang on investment prospects in China, entrepreneurship and Web3.0
Portfolio News
Asieris' Multinational Phase III Clinical Trial Has Completed Enrollment
Portfolio News
Insta360 Launches AI-powered 4K Camera Link to Redefine Remote Work
Portfolio News
GluBio Completes Series A+ Round of $22m to Advance Development of Novel TPD Drugs
Portfolio News
OriCell Therapeutics Raises Over $120m in Series B Financing

07/2022

Portfolio News
Chatail Completes Series B Financing Round Led by Qiming Venture Partners
Portfolio News
Qiming's Portfolio Company InventisBio Lists on STAR Market
Qiming News
Qiming Venture Partners Announces Closing of US$3.2b Funds

Pages